# | Title | Journal | Year | Citations |
---|
1 | Targeting Notch signalling pathway of cancer stem cells | Stem Cell Investigation | 2018 | 234 |
2 | A revealing review of mesenchymal stem cells therapy, clinical perspectives and Modification strategies | Stem Cell Investigation | 2019 | 164 |
3 | Clinical potential of mesenchymal stem/stromal cell-derived extracellular vesicles | Stem Cell Investigation | 2017 | 131 |
4 | Stem cell-based regenerative medicine | Stem Cell Investigation | 2019 | 125 |
5 | Stem cells from human hair follicles: first mechanical isolation for immediate autologous clinical use in androgenetic alopecia and hair loss | Stem Cell Investigation | 2017 | 101 |
6 | Current state of stem cell-based therapies: an overview | Stem Cell Investigation | 2020 | 84 |
7 | Lung cancer stem cells—origin, characteristics and therapy | Stem Cell Investigation | 2018 | 81 |
8 | The past, present, and future of CRM1/XPO1 inhibitors | Stem Cell Investigation | 2019 | 77 |
9 | Breast cancer stem cells—from origins to targeted therapy | Stem Cell Investigation | 2017 | 65 |
10 | Beneficial effects of exosomes secreted by cardiac-derived progenitor cells and other cell types in myocardial ischemia | Stem Cell Investigation | 2017 | 63 |
11 | Immune checkpoint blockade for hematologic malignancies: a review | Stem Cell Investigation | 2017 | 59 |
12 | Exosomal therapy—a new frontier in regenerative medicine | Stem Cell Investigation | 2021 | 55 |
13 | Extracellular vesicles and aging | Stem Cell Investigation | 2017 | 54 |
14 | Extracellular vesicles as regulators of tumor fate: crosstalk among cancer stem cells, tumor cells and mesenchymal stem cells | Stem Cell Investigation | 2017 | 54 |
15 | Engineering of extracellular vesicles as drug delivery vehicles | Stem Cell Investigation | 2017 | 54 |
16 | Bone marrow fibrosis in primary myelofibrosis: pathogenic mechanisms and the role of TGF-β | Stem Cell Investigation | 2016 | 52 |
17 | Telomere shortening as a hallmark of stem cell senescence | Stem Cell Investigation | 2019 | 49 |
18 | Breast cancer stem cells and the challenges of eradication: a review of novel therapies | Stem Cell Investigation | 2018 | 48 |
19 | Adipose-derived stem cells from lean and obese humans show depot specific differences in their stem cell markers, exosome contents and senescence: role of protein kinase C delta (PKCδ) in adipose stem cell niche | Stem Cell Investigation | 2016 | 41 |
20 | Immune reconstitution and outcomes after conditioning with anti-thymocyte-globulin in unrelated cord blood transplantation; the good, the bad, and the ugly | Stem Cell Investigation | 2017 | 40 |
21 | Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma | Stem Cell Investigation | 2016 | 39 |
22 | Stem-cell extracellular vesicles and lung repair | Stem Cell Investigation | 2017 | 39 |
23 | Stem Cell Ophthalmology Treatment Study: bone marrow derived stem cells in the treatment of Retinitis Pigmentosa | Stem Cell Investigation | 2018 | 38 |
24 | The biomarkers of leukemia stem cells in acute myeloid leukemia | Stem Cell Investigation | 2017 | 37 |
25 | Stem cell extracellular vesicles and kidney injury | Stem Cell Investigation | 2017 | 37 |
26 | Aberrant RNA splicing and mutations in spliceosome complex in acute myeloid leukemia | Stem Cell Investigation | 2017 | 36 |
27 | Adverse events, side effects and complications in mesenchymal stromal cell-based therapies | Stem Cell Investigation | 0 | 36 |
28 | microRNA regulation of human pancreatic cancer stem cells | Stem Cell Investigation | 2017 | 34 |
29 | GLIS1-3: emerging roles in reprogramming, stem and progenitor cell differentiation and maintenance | Stem Cell Investigation | 2017 | 34 |
30 | Platelet-rich plasma—an ‘Elixir’ for treatment of alopecia: personal experience on 117 patients with review of literature | Stem Cell Investigation | 2017 | 34 |
31 | Stem Cell Ophthalmology Treatment Study: bone marrow derived stem cells in the treatment of non-arteritic ischemic optic neuropathy (NAION) | Stem Cell Investigation | 2017 | 34 |
32 | Mini and customized low-cost bioreactors for optimized high-throughput generation of tissue organoids | Stem Cell Investigation | 2018 | 32 |
33 | Tyrosine kinase inhibitors targeting FLT3 in the treatment of acute myeloid leukemia | Stem Cell Investigation | 2017 | 31 |
34 | TNF-α, a good or bad factor in hematological diseases? | Stem Cell Investigation | 2014 | 31 |
35 | Mesenchymal stem cells as delivery vectors for anti-tumor therapy | Stem Cell Investigation | 2015 | 31 |
36 | Stem cell manipulation, gene therapy and the risk of cancer stem cell emergence | Stem Cell Investigation | 2017 | 30 |
37 | Megakaryopoiesis and platelet production: insight into hematopoietic stem cell proliferation and differentiation | Stem Cell Investigation | 2015 | 29 |
38 | Extracellular vesicle-mediated transport of non-coding RNAs between stem cells and cancer cells: implications in tumor progression and therapeutic resistance | Stem Cell Investigation | 2017 | 28 |
39 | Cancer stem cells: progress and challenges in lung cancer | Stem Cell Investigation | 2014 | 28 |
40 | Epithelial-mesenchymal plasticity—engaging stemness in an interplay of phenotypes | Stem Cell Investigation | 2019 | 27 |
41 | The role of mesenchymal stem/progenitor cells in sarcoma: update and dispute | Stem Cell Investigation | 2014 | 27 |
42 | Current development of chimeric antigen receptor T-cell therapy | Stem Cell Investigation | 2018 | 26 |
43 | Loss of heterogeneity, quiescence, and differentiation in muscle stem cells | Stem Cell Investigation | 2018 | 25 |
44 | Hypomethylating agents after allogeneic blood stem cell transplantation | Stem Cell Investigation | 2016 | 24 |
45 | Epigenetic regulation of human DCLK-1 gene during colon-carcinogenesis: clinical and mechanistic implications | Stem Cell Investigation | 2016 | 24 |
46 | Cell-based therapy for idiopathic pulmonary fibrosis | Stem Cell Investigation | 2019 | 24 |
47 | Alopecia and platelet-derived therapies | Stem Cell Investigation | 2017 | 23 |
48 | Cancer stem cells and exosome signaling | Stem Cell Investigation | 2015 | 23 |
49 | Indoleamine 2,3-dioxygenase and survivin peptide vaccine combined with temozolomide in metastatic melanoma | Stem Cell Investigation | 2017 | 22 |
50 | Investigation of multicellular tumor spheroids enriched for a cancer stem cell phenotype | Stem Cell Investigation | 2019 | 22 |